By the numbers

Too many Americans are skipping prescribed medications because they find them too expensive. That foretells trouble for payers—and for patients. On this page, you’ll find several relevant facts and numbers.

Average copayment and coinsurance for specialty drugs on their own tier

Source: Kaiser Family Foundation, 2017 Employer Health Benefits Survey, Sept. 19, 2017

Number of brand name drugs sold in the U.S. with coupons

Source: Cohen JP et al., Health Services Research, October 2017

Drug-price increases in U.S., 2007–2017

Source: AARP, “Trends in Retail Prices of Specialty Prescription Drugs Widely Used by Older Americans, 2006 to 2015,” September 2017

Out-of-pocket costs for cancer patients

*Among 300 patients treated at Duke University Medical Center
Source: Chino F et al, JAMA Oncology, November 2017

Percentages of Americans who report going without medications because they can’t afford them

Source: National Center for Health Statistics, Data Brief No. 184,” Strategies Used by Adults to Reduce Their Prescription Drug Costs: United States, 2013,” January 2015

Percentage of medical oncologists who think it’s important to be explicit about the potential financial impact of treatment choices

Source: Schrag D and Hanger M, Journal of Clinical Oncology, Jan. 10, 2007


A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report